Health care in 2025 was consumed by chaos, conflict and relentless drama. Think of President Barack Obama in 2009, with unified Democratic control of Congress and widespread voter frustration over health care costs and coverage. The likeliest response to pressure: Given the growing political pressure, drugmakers face a strategic choice. By shielding their most profitable products while conceding selectively on pricing, manufacturers can reduce political pressure without materially sacrificing profitability. Look for shifting political and economic climates to make 2026 a year of health care improvement, especially compared to 2025.